Work

Poster: AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00811-4

Authors: Naveen Pemmaraju, Branko Cuglievan, Joseph Lasky, Albert Kheradpour, Nobuko Hijiya, Anthony S. Stein, Soheil Meshinchi, Craig Mullen, Emanuele Angelucci, Luciana Vinti, Tariq I. Mughal, Anna Pawlowska

Institutions: The University of Texas MD Anderson Cancer Center, Cure 4 The Kids Foundation, Loma Linda University Children's Hospital, Columbia University Irving Medical Center, Columbia University, City Of Hope National Medical Center, University of Washington, University of Rochester Medicine, Golisano Children's Hospital, University of Rochester, Ospedale Policlinico San Martino, Bambino Gesù Children's Hospital, Tufts University, Stemline Therapeutics (United States)

Language: English

Topic: Histiocytic Disorders and Treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296531257

FWCI:

Cites:

Cited by:

Related to: 10